Fig. 4. Phosphoproteomic analysis of CRT0066101-treated MDA-MB-231 cells. (A) Flowchart of phosphoproteomic analysis. (B) Analysis of identified phosphoproteins, phosphopeptides, and phosphosites from the phosphoproteome. (C) Analysis of identified PRKD-regulated phosphoproteins, phosphopeptides, and phosphosites.